Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- JPMorgan trims AbbVie target, removes from Analyst Focus List
- Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
- Bristol Myers price target raised to $61 from $57 at BMO Capital
- Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls
- AbbVie price target lowered to $208 from $228 at BMO Capital